World Congestive Heart Failure (CHF) Treatment Devices Market Is Expected to Reach $14.8 Billion by 2022; Finds New Report
"Congestive Heart Failure (CHF) Treatment Devices Market" projects that the world CHF treatment devices market would reach $14.8 billion by 2022, at a CAGR of 5.5% from 2016 to 2022. Implantable cardioverter-defibrillator (ICDs) segment is expected to dominate the world CHF treatment devices market throughout the forecast period. North America is projected to continue its lead in terms of revenue, accounting for more than two-fifths share of the world CHF treatment devices.
View full press release